Kim L. Sandler

1 week ago | patientcareonline.com | Kim L. Sandler |Sydney Jennings

In this forward-looking conversation, Kim L. Sandler, MD, co-director of the Vanderbilt Lung Screening Program and associate professor of radiology and radiological sciences at Vanderbilt University Medical Center, shares her insights on the evolving challenges of lung cancer screening. Dr Sandler discusses the increasing incidence of lung cancer in people who have never smoked—particularly women—and emphasizes the need to re-evaluate who is eligible for screening.

2 weeks ago | patientcareonline.com | Kim L. Sandler |Sydney Jennings

Despite strong evidence supporting the effectiveness of lung cancer screening, only about 15% of eligible individuals in the US are currently enrolled in screening programs. In this conversation from ACP Internal Medicine Meeting 2025, Kim Sandler, MD, discusses the most pressing barriers to broader adoption—namely fear, lack of awareness, and stigma—and offers strategies for primary care providers to increase screening uptake.

2 weeks ago | patientcareonline.com | Kim L. Sandler |Sydney Jennings

At the American College of Physicians Internal Medicine Meeting 2025, April 3-5, in New Orleans, Kim L. Sandler, MD, sat down with Patient Care to discuss key takeaways from her presentation on lung cancer screening during the session titled "Clinical Triad: Lung Cancer in 2025: A New Day Is Dawning." Dr Sandler is the director of the Vanderbilt Lung Screening Program at Vanderbilt University Medical Center in Nashville, Tennessee.

2 weeks ago | patientcareonline.com | Kim L. Sandler |Sydney Jennings

The following transcript has been edited for clarity, style, and length. Patient Care: You also mentioned the importance of shared decision-making in lung cancer screening. How can primary care physicians effectively engage their patients in this process? Kim Sandler, MD: Lung cancer screening is unique in that it was the first imaging study to require a shared decision-making visit.